Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib ± panitumumab in MET-amplified metastatic colorectal cancer
jRCT2080224606Phase 2Completed
- Sponsor
- National Cancer Center Hospital East
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cabozantinib in metastatic colon cancer (mCRC) and colorectal cancer (CRC) (2 arms), sponsored by National Cancer Center Hospital East. Started Mar 2019; status: completed.
02
Drugs
cabozantinib
03
Conditions
metastatic colon cancer (mCRC)colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT2080224606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224606.